Process Engineer at Bristol-Myers Squibb

Leiden, South Holland, Netherlands

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, Life SciencesIndustries

Requirements

  • Education/Experience/Licenses/Certifications (specifics not detailed in provided description)
  • Ability to work shift work
  • Willingness to travel occasionally for training purposes
  • Based in Leiden, The Netherlands

Responsibilities

  • Act as SME for processes being technology transferred into the BMS Leiden Cell Therapy Facility
  • Prepare for and own process validation activities
  • Continuously monitor, analyze, and optimize the end-to-end process and anticipate and permanently resolve issues that may arise during production
  • Provide technical input and act as lead investigator for process related deviations, ensuring compliance with internal standards and regulatory requirements
  • Author, review and approve the content of technical documentation (e.g. investigations, changes, SOPs and batch records, protocols and reports)
  • Act as SME and lead interactions on behalf of MSAT during production campaigns in both the shopfloor and Front-Line Support; provide prompt input on resolution of events occurring during manufacturing; responsible for troubleshooting
  • Support the change initiatives and the implementation of process improvement initiatives; drive and own change controls and change actions; responsible for MSAT impact assessments
  • Support the Technology Transfer and production of BMS CAR-T products for both global clinical trials and commercial supply
  • Support process validation activities
  • Collaborate with SMEs from the Development, Manufacturing, and Quality teams
  • Provide key technical support during the technology transfer stage of projects
  • Support the resolution of process deviations, the evaluation and implementation of process changes
  • Provide continuous improvement support to Manufacturing Operations to ensure rapid, flawless, compliant, and cost-effective delivery of quality products

Skills

Process Engineering
Cell Therapy Manufacturing
Production Optimization
Biomanufacturing
GMP

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI